Camp4 Therapeutics Corporation · NASDAQ:CAMP
Balyasny Asset Management L.P. reported a 5.07% stake in Camp4 Therapeutics Corporation (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Balyasny Asset Management L.P. reported a 5.07% stake in Camp4 Therapeutics Corporation, 2,632,437 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.07%
- Shares
- 2,632,437
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Balyasny Asset Management L.P. | 5.07% | 2,632,437 |
| BAM GP LLC | 5.07% | 2,632,437 |
| Balyasny Asset Management Holdings LP | 5.07% | 2,632,437 |
| Dames GP LLC | 5.07% | 2,632,437 |
| Dmitry Balyasny | 5.07% | 2,632,437 |
Source
Related
- Camp4 Therapeutics Corporation
- Balyasny Asset Management L.P.
- Camp4 Therapeutics Corporation shareholders
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Gold Kelly · Sep 2, 2026
- Form 4 · Schwab Andrew J. · Aug 31, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026